Journal of the Neurological Sciences
Volume 205, Issue 1 , Pages 51-58 , 15 December 2002

Quality of life in patients with multiple sclerosis: The impact of fatigue and depression

  • Vallabh Janardhan

      Affiliations

    • Department of Neurology, Boston University Medical Center, Boston, MA, USA
    • ,
  • Rohit Bakshi

      Affiliations

    • Corresponding Author InformationCorresponding author. Buffalo Neuroimaging Analysis Center, Jacobs Neurological Institute, 100 High Street, Buffalo, NY 14203, USA. Tel.: +1-716-859-7592; fax: +1-716-876-8172.
    • Department of Neurology, State University of New York at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY, USA
    • Department of Imaging Services, Kaleida Health, Buffalo, NY, USA
    • Buffalo Neuroimaging Analysis Center, Jacobs Neurological Institute, Buffalo, NY, USA

Received 9 May 2002 ,Revised 30 July 2002 ,Accepted 5 August 2002.

References 

  1. Vickrey BG, Hays RD, Harooni R, Myers LW, Ellison GW. A health-related quality of life measure for multiple sclerosis. Qual. Life Res. 1995;4:187–206
  2. Janardhan V, Bakshi R. Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis. Arch. Neurol. 2000;57:1485–1491
  3. Henriksson F, Fredrikson S, Masterman T, Jonsson B. Costs, quality of life and disease severity in multiple sclerosis: a cross-sectional study in Sweden. Eur. J. Neurol. 2001;8:27–35
  4. Burden of illness of multiple sclerosis: Part II. Quality of life. The Canadian Burden of Illness Study Group. Can J Neurol Sci 1998;25:31–8.
  5. Nortvedt MW, Riise T, Myhr KM, Nyland HI. Quality of life in multiple sclerosis: measuring the disease effects more broadly. Neurology. 1999;53:1098–1103
  6. Pfennings L, Cohen L, Ader H, et al.  Exploring differences between subgroups of multiple sclerosis patients in health-related quality of life. J. Neurol. 1999;246:587–591
  7. Nortvedt MW, Riise T, Myhr KM, Nyland HI. Quality of life as a predictor for change in disability in MS. Neurology. 2000;55:51–54
  8. Modrego PJ, Pina MA, Simon A, Azuara MC. The interrelations between disability and quality of life in patients with multiple sclerosis in the area of Bajo Aragon, Spain: a geographically based survey. Neurorehabil. Neural Repair. 2001;15:69–73
  9. O'Connor P, Lee L, Ng PT, Narayana P, Wolinsky JS. Determinants of overall quality of life in secondary progressive MS: a longitudinal study. Neurology. 2001;57:889–891
  10. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch. Neurol. 1989;46:1121–1123
  11. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The impact of fatigue on patients with multiple sclerosis. Can. J. Neurol. Sci. 1994;21:9–14
  12. Colosima C, Millefiorini E, Grasso MG, et al.  Fatigue in MS is associated with specific clinical features. Acta Neurol. Scand. 1995;92:353–355
  13. Bergamaschi R, Romani A, Versino M, Poli R, Cosi V. Clinical aspects of fatigue in multiple sclerosis. Funct. Neurology. 1997;12:247–251
  14. Bakshi R, Shaikh ZA, Miletich RS, et al.  Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult. Scler. 2000;6:181–185
  15. Minden SL, Schiffer RB. Affective disorders in multiple sclerosis. Review and recommendations for clinical research. Arch. Neurol. 1990;47:98–104
  16. Krupp LB, Coyle PK, Doscher C, et al.  Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology. 1995;45:1956–1961
  17. Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J. Affect. Disord. 2000;58:19–36
  18. Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann. Neurol. 1996;39:432–441
  19. Lengdobler H, Kiessling WR. Group music therapy in multiple sclerosis: initial report of experience. Psychother. Psychosom. Med. Psychol. 1989;39:369–373
  20. Sandyk R. Treatment with weak electromagnetic fields improves fatigue associated with multiple sclerosis. Int. J. Neurosci. 1996;84:177–186
  21. Krupp LB, Pollina DA. Mechanisms and management of fatigue in progressive neurological disorders. Curr. Opin. Neurol. 1996;9:456–460
  22. Poser CM, Paty DW, Scheinberg L, et al.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 1983;13:227–231
  23. Bakshi R, Miletich RS, Henschel K, et al.  Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71 patients. Neurology. 1999;53:1151–1153
  24. Mohr DC, Goodkin DE, Likosky W, Gatto N, Baumann KA, Rudick RA. Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch. Neurol. 1997;54:531–533
  25. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 4th ed.. Washington, DC: American Psychiatric Association; 1994;
  26. Vickrey BG, Hays RD, Genovese BJ, Myers LW, Ellison GW. Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis. J. Clin. Epidemiol. 1997;50:557–569
  27. Solari A, Filippini G, Mendozzi L, et al.  Validation of Italian multiple sclerosis quality of life 54 questionnaire. J. Neurol. Neurosurg. Psychiatry. 1999;67:158–162
  28. Vernay D, Gerbaud L, Biolay S, et al.  Quality of life and multiple sclerosis: validation of the French version of the self-questionnaire (SEP-59). Rev. Neurol. (Paris). 2000;156:247–263
  29. Ware JE, Snow KK, Kosinsky M, Gandek B. SF-36 health survey manual and interpretation guide. Boston, MA: New England Medical Center, Health Institute; 1993;
  30. Lublin FD, Reingold SC  for the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis . Defining the clinical course of multiple sclerosis: results of an international survey. Neurology. 1996;46:907–911
  31. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444–1452
  32. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Arch. Neurol. 1988;45:435–437
  33. Roelcke U, Kappos L, Lechner-Scott J, et al.  Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study. Neurology. 1997;48:1566–1571
  34. Reynolds WM, Kobak KA. Hamilton depression inventory. A self-report version of the Hamilton depression rating scale (HDRS). Odessa: Psychological Assessment Services; 1995;
  35. Thompson AJ. Measuring handicap in multiple sclerosis. Mult. Scler. 1999;5:260–262
  36. Rothwell PM. Quality of life in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 1998;65:433
  37. Truyen L, van Waesberghe JHTM, van Walderveen MAA, et al.  Accumulation of hypointense lesions (“black holes”) on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology. 1996;47:1469–1476
  38. Bakshi R, Benedict RH, Bermel RA, Jacobs L. Regional brain atrophy is associated with physical disability in multiple sclerosis: semiquantitative magnetic resonance imaging and relationship to clinical findings. J. Neuroimaging. 2001;11:129–136
  39. Wang JL, Reimer MA, Metz LM, Patten SB. Major depression and quality of life in individuals with multiple sclerosis. Int. J. Psychiatry Med. 2000;30:309–317
  40. Bakshi R, Czarnecki D, Shaikh ZA, et al.  Brain MRI lesions and atrophy are related to depression in multiple sclerosis. NeuroReport. 2000;11:1153–1158
  41. Zorzon M, de Masi R, Nasuelli D, et al.  Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects. J. Neurol. 2001;248:416–421
  42. Bakshi R, Miletich RS, Kinkel PR, Emmet ML, Kinkel WR. High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis. J. Neuroimaging. 1998;8:228–234
  43. Bakshi R, Miletich RS, Czarnecki D, Kinkel PR, Emmet ML, Kinkel WR. Depression in multiple sclerosis is associated with widespread cerebral gray matter and white matter glucose hypometabolism: a prospective fluorodeoxyglucose positron emission tomography study (abstract). Neurology. 1998;50:A323
  44. Cutajar R, Ferriani E, Scandellari C, et al.  Cognitive function and quality of life in multiple sclerosis patients. J. Neurovirology. 2000;6:S186–S190
  45. Benedict RHB, Priore RL, Miller C, Munschauser F, Jacobs L. Personality disorder in MS correlates with cognitive impairment. J. Neuropsychiatr. Clin. Neurosci. 2001;13:70–76
  46. Nortvedt MW, Riise T, Myhr KM, Landtblom AM, Bakke A, Nyland HI. Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Mult. Scler. 2001;7:231–235

PII: S0022-510X(02)00312-X

Journal of the Neurological Sciences
Volume 205, Issue 1 , Pages 51-58 , 15 December 2002

Article Tools

* Image Usage & Resolution